7 March 2006
Major biomarker candidates for Alzheimer's disease explored holds promise for improving the diagnosis and management of dementia
Alzheimer's disease--specific biomarkers clearly are needed for the differential diagnosis of cognitive impairment in the elderly.
23 February 2006
A better tool to study role of iron in Alzheimer's, Parkinson's
Engineers have found a way to pinpoint and identify the tiny iron oxide particles associated with Alzheimer's and other neurodegenerative diseases in the brain.
23 January 2006
Age-related memory improvement linked with consumption of apple products
New study finds consuming apple juice associated with brain health
12 January 2006
Journal of Alzheimer's Disease is devoted to metal ions and neurodegenerative diseases
The human body contains many metals, from the iron in hemoglobin to the calcium in bones. Other metals, usually in trace amounts, participate in many metabolic and degenerative processes.
15 December 2005
Professors discover how being overweight or obese leads to Alzheimer's
In a world first, scientists have discovered how being overweight or obese creates a high risk for Alzheimer's.
1 December 2005
Alzheimer and Type 2 Diabetes: A New Step Toward Prevention
“The two pathologies share biological risk factors” based on research conducted by the Neurosciences Department of the University of Genoa investigating cases of degenerative pathologies. These studies were directed by Dr.
30 November 2005
Insulin levels drop with progression of Alzheimer's disease, linked to tangles in brain
Further evidence that Alzheimer's is a type of diabetes
6 October 2005
A molecular basis for selective therapeutic intervention in Alzheimer's disease
Alzheimer's disease, a complex neurological disorder, has as one of its hallmarks the presence of senile plaques in the brains of affected individuals. These senile plaques are rich in a toxic amyloid peptide termed Aß.
3 October 2005
Intake of dietary copper helps Alzheimer's patients
As one of the services for patients with Alzheimer's disease, the Department of Psychiatry at the Saarland University Medical Center offers participation in a clinical phase II trial.
Pages
